38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fentanyl 200 microgram oromucosal lozenge	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely doxycycline calcium 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely doxycycline calcium 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation	Count of base of active ingredient	False	un	Inferred relationship	Some
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Salbutamol (as salbutamol sulfate) 210 microgram/mL solution for inhalation	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Salbutamol (as salbutamol sulfate) 210 microgram/mL solution for inhalation	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Aripiprazole 10 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Aripiprazole 10 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pantoprazole (as pantoprazole sodium) 40 milligram/1 sachet conventional release oral granules (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pantoprazole (as pantoprazole sodium) 40 milligram/1 sachet conventional release oral granules (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely baclofen 20 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely baclofen 20 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Estriol 500 microgram vaginal pessary	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Estriol 500 microgram vaginal pessary	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Estrone 15 mg/mL suspension for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Estrone 15 mg/mL suspension for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Siltuximab 400 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Siltuximab 400 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ciclesonide 50 microgram/actuation nasal spray	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely belimumab 120 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Miconazole nitrate 1.2 g vaginal capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Miconazole nitrate 1.2 g vaginal capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Pegvisomant 15 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pegvisomant 15 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Lamotrigine 100 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lamotrigine 100 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Sulfanilamide 1.05 g vaginal pessary	Count of base of active ingredient	False	un	Inferred relationship	Some
Sulfanilamide 1.05 g vaginal pessary	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution	Has concentration strength numerator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Miconazole nitrate 100 mg vaginal pessary	Count of base of active ingredient	False	un	Inferred relationship	Some
Miconazole nitrate 100 mg vaginal pessary	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Palifermin 6.25 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Palifermin 6.25 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Anidulafungin 50 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Anidulafungin 50 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1

Start Previous Page 182 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module